Effect of weight loss on renal function in overweight and obese patients with heart failure

Marjan Motie, Lorraine Evangelista, Dawn Lombardo, Josiah Hoi, Tamara B. Horwich, Michele Hamilton, Gregg C. Fonarow

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aims The effect of intentional weight loss on glomerular filtration rate (GFR) in overweight and obese patients with heart failure (HF), diabetes mellitus (DM) and/or metabolic syndrome (MS) has not been studied. The purpose of the present study is to assess the short term effects of intentional weight loss on renal function in this population. Materials and methods Fifty nine patients were recruited to participate in a 3-month intensive behavioral weight management intervention and received one of two standard structured energy-restricted meal plans (1200 or 1500 kcal/day) based on their computed calorie deficit. Weight and renal function (serum creatinine, BUN and estimated glomerular filtration rate based on two formulas – Modification in Renal Disease Study (MDRD), and modified version of Cockcroft-Gault formula reported by Salazar Corcoran for obese patients (absolute and relative formulas) – were evaluated at baseline and at 3 months. Results Participants had eGFR in the normal range at baseline and lost an average of 7.56 ± 14.9 pounds (p < 0.0001) over 3 months; however, there was no significant reduction in serum creatinine, BUN or eGFR. Conclusion This study provides evidence that intentional weight loss in overweight and obese patients with HF along with DM, and/or MS and normal baseline renal function does not adversely affect renal function overtime.

Original languageEnglish (US)
Pages (from-to)95-98
Number of pages4
JournalDiabetes and Metabolic Syndrome: Clinical Research and Reviews
Volume11
Issue number2
DOIs
StatePublished - Apr 1 2017
Externally publishedYes

Fingerprint

Weight Loss
Heart Failure
Kidney
Blood Urea Nitrogen
Glomerular Filtration Rate
Creatinine
Diabetes Mellitus
Weights and Measures
Serum
Meals
Reference Values
Population

Keywords

  • Heart failure
  • Hyperfiltration
  • Obesity
  • Renal function
  • Weight loss

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of weight loss on renal function in overweight and obese patients with heart failure. / Motie, Marjan; Evangelista, Lorraine; Lombardo, Dawn; Hoi, Josiah; Horwich, Tamara B.; Hamilton, Michele; Fonarow, Gregg C.

In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 11, No. 2, 01.04.2017, p. 95-98.

Research output: Contribution to journalArticle

Motie, Marjan ; Evangelista, Lorraine ; Lombardo, Dawn ; Hoi, Josiah ; Horwich, Tamara B. ; Hamilton, Michele ; Fonarow, Gregg C. / Effect of weight loss on renal function in overweight and obese patients with heart failure. In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2017 ; Vol. 11, No. 2. pp. 95-98.
@article{eb4733633394439891584cef4f24fa98,
title = "Effect of weight loss on renal function in overweight and obese patients with heart failure",
abstract = "Aims The effect of intentional weight loss on glomerular filtration rate (GFR) in overweight and obese patients with heart failure (HF), diabetes mellitus (DM) and/or metabolic syndrome (MS) has not been studied. The purpose of the present study is to assess the short term effects of intentional weight loss on renal function in this population. Materials and methods Fifty nine patients were recruited to participate in a 3-month intensive behavioral weight management intervention and received one of two standard structured energy-restricted meal plans (1200 or 1500 kcal/day) based on their computed calorie deficit. Weight and renal function (serum creatinine, BUN and estimated glomerular filtration rate based on two formulas – Modification in Renal Disease Study (MDRD), and modified version of Cockcroft-Gault formula reported by Salazar Corcoran for obese patients (absolute and relative formulas) – were evaluated at baseline and at 3 months. Results Participants had eGFR in the normal range at baseline and lost an average of 7.56 ± 14.9 pounds (p < 0.0001) over 3 months; however, there was no significant reduction in serum creatinine, BUN or eGFR. Conclusion This study provides evidence that intentional weight loss in overweight and obese patients with HF along with DM, and/or MS and normal baseline renal function does not adversely affect renal function overtime.",
keywords = "Heart failure, Hyperfiltration, Obesity, Renal function, Weight loss",
author = "Marjan Motie and Lorraine Evangelista and Dawn Lombardo and Josiah Hoi and Horwich, {Tamara B.} and Michele Hamilton and Fonarow, {Gregg C.}",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.dsx.2016.06.026",
language = "English (US)",
volume = "11",
pages = "95--98",
journal = "Diabetes and Metabolic Syndrome: Clinical Research and Reviews",
issn = "1871-4021",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Effect of weight loss on renal function in overweight and obese patients with heart failure

AU - Motie, Marjan

AU - Evangelista, Lorraine

AU - Lombardo, Dawn

AU - Hoi, Josiah

AU - Horwich, Tamara B.

AU - Hamilton, Michele

AU - Fonarow, Gregg C.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Aims The effect of intentional weight loss on glomerular filtration rate (GFR) in overweight and obese patients with heart failure (HF), diabetes mellitus (DM) and/or metabolic syndrome (MS) has not been studied. The purpose of the present study is to assess the short term effects of intentional weight loss on renal function in this population. Materials and methods Fifty nine patients were recruited to participate in a 3-month intensive behavioral weight management intervention and received one of two standard structured energy-restricted meal plans (1200 or 1500 kcal/day) based on their computed calorie deficit. Weight and renal function (serum creatinine, BUN and estimated glomerular filtration rate based on two formulas – Modification in Renal Disease Study (MDRD), and modified version of Cockcroft-Gault formula reported by Salazar Corcoran for obese patients (absolute and relative formulas) – were evaluated at baseline and at 3 months. Results Participants had eGFR in the normal range at baseline and lost an average of 7.56 ± 14.9 pounds (p < 0.0001) over 3 months; however, there was no significant reduction in serum creatinine, BUN or eGFR. Conclusion This study provides evidence that intentional weight loss in overweight and obese patients with HF along with DM, and/or MS and normal baseline renal function does not adversely affect renal function overtime.

AB - Aims The effect of intentional weight loss on glomerular filtration rate (GFR) in overweight and obese patients with heart failure (HF), diabetes mellitus (DM) and/or metabolic syndrome (MS) has not been studied. The purpose of the present study is to assess the short term effects of intentional weight loss on renal function in this population. Materials and methods Fifty nine patients were recruited to participate in a 3-month intensive behavioral weight management intervention and received one of two standard structured energy-restricted meal plans (1200 or 1500 kcal/day) based on their computed calorie deficit. Weight and renal function (serum creatinine, BUN and estimated glomerular filtration rate based on two formulas – Modification in Renal Disease Study (MDRD), and modified version of Cockcroft-Gault formula reported by Salazar Corcoran for obese patients (absolute and relative formulas) – were evaluated at baseline and at 3 months. Results Participants had eGFR in the normal range at baseline and lost an average of 7.56 ± 14.9 pounds (p < 0.0001) over 3 months; however, there was no significant reduction in serum creatinine, BUN or eGFR. Conclusion This study provides evidence that intentional weight loss in overweight and obese patients with HF along with DM, and/or MS and normal baseline renal function does not adversely affect renal function overtime.

KW - Heart failure

KW - Hyperfiltration

KW - Obesity

KW - Renal function

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=85004190487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85004190487&partnerID=8YFLogxK

U2 - 10.1016/j.dsx.2016.06.026

DO - 10.1016/j.dsx.2016.06.026

M3 - Article

VL - 11

SP - 95

EP - 98

JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

SN - 1871-4021

IS - 2

ER -